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Abstract: Dinuclear platinum(II) complexes [{PtCl2(PPh3)}2(µ-N—N)], where N—N is a divergent 
bidentate nitrogen ligand, were prepared by reacting cis-[PtCl2(PPh3)(NCMe)] with N―N in a 
Pt/N―N molar ratio 2. The (trans,trans)-isomers were obtained as kinetic products and recovered 
in good yields and high purity {1, N—N = pyrazine (pyrz); 2, N—N = 4,4'-bipyridyl (bipy); 3, N—
N = piperazine (pipz); 4, N—N = p-xylylendiamine (xylN2)}. cis-[PtCl2(PPh3)(NCMe)] was also 
reacted with the tridentate divergent ligand 2,4,6-tris-(pyrid-4'-yl)1,3,5-triazine (py3TRIA) in molar 
ratio 3 with formation of the trinuclear (trans,trans,trans)-[{PtCl2(PPh3)}3(µ-py3TRIA)], 5. On the 
other hand, the treatment of cis-[PtCl2(PPh3)(NCMe)] with the monodentate pyridine (py) produced 
a mixture of both trans-[PtCl2(PPh3)(py)] (6a) and cis-[PtCl2(PPh3)(py)] (6b). The reactions of cis-
[PtCl2(PPh3)(NCMe)] with N―N = pyrz, bipy, pipz, carried out with a Pt/ N―N molar ratio 1, 
were monitored by 
31
P-NMR spectroscopy. Equilibria were observed in solution, involving 
dinuclear (trans-trans)-[{PtCl2(PPh3)}2(µ-N―N)], mononuclear [PtCl2(PPh3)(N―N)] and free 
N―N. The addition of an excess of the divergent ligand allowed the complete conversion to the 
corresponding mononuclear complexes. With the heteroaromatic ligands both geometric isomers 
were observed (7a, 7b and 8a, 8b, for pyrz and bipy derivatives, respectively) while with pipz the 
trans-isomer only was detected, 9. In the system involving bipy, the scarcely soluble dinuclear 
(cis,cis)-[{PtCl2(PPh3)}2(µ-bipy)], 2b, was also obtained. Products 2, 2b, 3·2(CHCl3) and 
6a·0.5(C2H4Cl2) were structurally characterized by single crystal X-Ray diffraction methods. 
Keywords: platinum(II); triphenylphosphine; dinuclear complexes; divergent ligands; cis-trans 
isomerism. 
 
 
1. Introduction 
 
Divergent ligands are molecules containing at least two functional groups able to coordinate metal 
ions in a non-chelating fashion to afford oligo- or polynuclear architectures. In the field of platinum 
complexes, N-donor divergent bidentate ligands constitute important building blocks in the 
synthesis of polynuclear 2D and 3D supramolecular derivatives,[1] with potential applications in 
the fields of luminescent materials[2] and medicinal chemistry.[3] While ionic supramolecular 
coordination compounds of platinum (mainly tri- and tetranuclear) originate from well-studied self-
assembly procedures,[4,5] much less is known about neutral dinuclear complexes.[6] Thus, with the 
aim to prepare dinuclear species and in the context of our studies concerning the synthesis of 
platinum(II) complexes containing the PPh3 ligand,[7] the reactivity of cis-
[PtCl2(PPh3)(NCMe)][7e] towards N—N divergent bidentate nitrogen donor ligands (pyrz, bipy, 
pipz and xylN2) has been investigated. In addition, the reactivity towards the tridentate 2,4,6-tris-
(pyrid-4'-yl)1,3,5-triazine) (py3TRIA)[8] was studied. The use of a precursor with a single available 
coordination site on platinum, due to the facile nitrile substitution, prevents the formation of 
derivatives with a nuclearity higher than the denticity of the divergent ligand. Moreover, the 
presence of the phosphorous donor ligand in the platinum coordination sphere influences the 
stereochemistry of the processes; in addition it allows the tracking of the reactions via 
31
P-NMR 
spectroscopy providing useful pieces of information also in the presence of equilibria involving 
several species. The outcome of the reactions in dependence on the molar ratio between reagents is 
here reported and discussed, as well as the stereochemistry of the products. 
 
2. Experimental 
2.1. Materials and general methods 
 All manipulations were performed under a dinitrogen atmosphere, if not otherwise stated. 
Solvents and liquid reagents were dried according to reported procedures [9]. 
1
H-, 
13
C-, 
31
P and 
195Pt NMR spectra were recorded with a Bruker ‘‘Avance DRX400’’ spectrometer, in CDCl3 
solution if not otherwise stated. Chemical shifts were measured in ppm (δ) from TMS by residual 
solvent peaks for 
1
H and 
13
C, from aqueous (D2O) H3PO4 (85%) for 
31
P and from aqueous (D2O) 
hexachloroplatinic acid for 
195
Pt. A sealed capillary containing C6D6 was introduced in the NMR 
tube to lock the spectrometer to the deuterium signal when non-deuterated solvents were used. 
FTIR spectra in solid phase were recorded with a Perkin–Elmer ‘‘Spectrum One’’ spectrometer, 
equipped with an ATR accessory. Elemental analyses (C, H, N) were performed at Dipartimento di 
Scienze e Tecnologie Chimiche, Università di Udine. Cis-[PtCl2(PPh3)(NCMe)],[7e]
 
trans-[Pt2(µ-
Cl)2Cl2(PPh3)2] [7e] and 2,4,6-tris-(pyrid-4'-yl)-1,3,5-triazine[8] were prepared according to a 
reported procedure. In the text the following abbreviations were used: 4,4'-bipyridyl (bipy); 
pyrazine (pyrz); piperazine (pipz); p-xylylendiamine (xylN2); pyridine (py); 2,4,6-tris-(pyrid-4'-yl)-
1,3,5-triazine (py3TRIA); 1,2-dichloroethane (1,2-DCE). 
2.2. General procedure for the synthesis of dinuclear species (trans,trans)-[{PtCl2(PPh3)}2(µ-
N―N)] 
 A suspension of cis-[PtCl2(PPh3)(NCMe)] (≈ 1.0 mmol) in 1,2-DCE (5.0-10.0 mL) was 
treated with a solution of the divergent ligand N―N in the minimal amount of the same solvent 
(Pt/N―N molar ratio = 2.0). The resulting yellow solution was refluxed under stirring until the 
complete conversion was obtained (
31
P-NMR). A yellow, fine solid separated out of the solution on 
cooling to room temperature (25 °C) or after heptane addition (10.0-15.0 mL). The solid was 
filtered, washed with two portions of heptane and dried under vacuum (10
-2
 mmHg). For each 
dinuclear complex the isolated product % yield, the elemental analysis and the spectroscopic (IR 
and NMR) characterization are reported below. 
2.2.1 (Trans,trans)-[{PtCl2(PPh3)}2(µ-pyrz)], 1. 
 73 % yield. Anal. Calcd. for C40H34Cl4N2P2Pt2: C 42.3, H 3.0, N 2.5 %. Found: C 42.0, H 
2.8, N 2.4 %. IR (ATR, cm
-1
): 3107, 1484, 1435, 1422, 1167, 1098, 879, 744, 690;
 1
H-NMR: 9.33 
(m, 4H, NCH), 7.79 (m, 12H, Harom phosphine), 7.48 (m, 18H, Harom phosphine); 
13
C-NMR: 147.1, 
134.9 (JC-P = 10.0 Hz), 131.2, 128.2, 128.3 (
1
JC-P = 63.0 Hz), 128.2 (JC-P = 11.0 Hz); 
31
P-NMR: 2.80 
(
1
JP-Pt = 3725 Hz); 
195
Pt-NMR: -3561 (
1
JPt-P = 3725 Hz). 
2.2.2.(Trans,trans)-[{PtCl2(PPh3)}2(µ-bipy)], 2. 
 60 % yield. Anal. Calcd. for C46H38Cl4N2P2Pt2: C 45.6, H 3.2, N 2.3 %.  Found: C 45.3, H 
3.0, N 2.3 %. IR (ATR, cm
-1
): 3052; 1610; 1481; 1220; 1095; 812; 743; 690.; 
1
H-NMR: 9.22 (m, 
4H, NCH), 7.83 (m, 12H, Harom phosphine), 7.68 (m, 4H, NCHCH), 7.47 (m, 18H, Harom 
phosphine); 
13
C-NMR: 152.2, 146.3, 134.9 (JC-P = 10.3 Hz), 131.0, 128.5 (
1
JC-P = 65.3 Hz), 128.0 
(JC-P = 11.3 Hz), 122.8; 
31
P-NMR: 2.64 (
1
JP-Pt = 3611 Hz); 
195
Pt-NMR: -3538 (
1
JPt-P = 3611 Hz);. A 
sample of solid was dissolved in CHCl3 and crystallized by slow diffusion of pentane vapors. A 
single crystal was selected for X-ray diffraction analysis, which confirmed the (trans,trans) 
stereochemistry.  
2.2.3.(Trans,trans)-[{PtCl2(PPh3)}2(µ-pipz)], 3. 
 91 % yield. Anal. Calcd. for C40H40Cl4N2P2Pt2: C 42.0, H 3.5, N 2.5 %. Found: C 41.8, H 3.3, 
N 2.6%. IR (ATR, cm
-1
): 3227; 3190; 3055; 1482; 1098; 880; 745; 690;
 1
H-NMR: 7.69 (m, 12H, 
Harom), 7.43 (m, 18H, Harom), 3.96 (bs, 
2
JH-Pt = 68.5 Hz, 2H, NH), 3.58 (m, 4H, CHH), 3.36 (m, 4H, 
CHH). 
13
C-NMR: 134.8 (JC-P = 10.0 Hz), 131.0, 128.3 (
1
JC-P = 63.0 Hz), 128.0 (JC-P = 11.0 Hz), 
48.7; 
31
P-NMR: 3.56 (
1
JP-Pt = 3603 Hz); 
195
Pt-NMR: -3606 (
1
JPt-P = 3603 Hz);. A sample of solid 
was dissolved in CHCl3 and crystallized by slow diffusion of pentane vapors. A single crystal was 
selected for X-ray diffraction analysis, which confirmed trans,trans geometry. 
2.2.4. (Trans,trans)-[{PtCl2(PPh3)}2(µ-xylN2)], 4. 
37 % yield. Anal. Calcd. for C44H42Cl4N2P2Pt2: C 44.3, H 3.6, N 2.4 %. Found: C 44.1, H 3.4, N 
2.4%. IR (ATR, cm
-1
): 3207; 3056; 1568; 1098; 990; 743; 691; 
1
H-NMR: 7.73 (m, 10H, Harom), 
7.45 (m, 24H, Harom), 4.25 (m, 4H), 3.60 (m, 4H); 
13
C-NMR: 138.2, 134.8 (JC-P = 10.0 Hz), 131.0 
(JC-P = 2.0 Hz), 129.2, 128.5 (
1
JC-P = 63.0 Hz), 128.0 (JC-P = 11.0 Hz), 48.1; 
31
P-NMR: 3.87 (
1
JP-Pt = 
3646 Hz); 
195
Pt-NMR: -3606 (
1
JPt-P = 3646 Hz);  
2.3.Preparation of mononuclear derivatives 
2.3.1. Synthesis of trans- + cis-[PtCl2(PPh3)(Py)] (6a + 6b) 
A suspension of cis-[PtCl2(PPh3)(NCMe)] (0.254 g, 0.445 mmol) in 15.0 mL of 1,2-DCE was 
treated, under stirring, with pyridine (Py/Pt molar ratio = 1.1). The reaction was monitored by 
31
P-
NMR spectroscopy. The mixture was refluxed until the precursor signal disappeared, substituted by 
two new signals (2h), then it was cooled. A fine yellow precipitate was filtered, washed with cold 
heptane and dried under vacuum (10
-2
 mmHg). 64 % yield. Anal. Calcd. for C23H20Cl2NPPt·1/2 
C2H4Cl2: C 43.9, H 3.4, N 2.1 %. Found: C 43.7, H 3.8, N 2.0 %. IR (ATR, cm
-1
): 3064; 1481; 
1096; 996; 752; 690; 
1
H-NMR (solvent, the two trans and cis isomers, 6a and 6b, in approximately 
1:1 molar ratio, were observed): 9.03 (m, 2H, 
3
JH-Pt = 32 Hz, NCH, trans isomer), 8.45 (m, 2H, 
3
JH-
Pt = 40 Hz, NCH cis isomer), 7.83 (m, 8H), 7.69 (m, 6H), 7.45 (m, 14H), 7.33 (m, 6H), 6.93 (m, 
2H); 
13
C-NMR (trans and cis isomers): 153.4, 151.4, 138.5, 137.4, 134.7 (JC-P = 10.0 Hz), 134.6 (JC-
P = 10.0 Hz), 131.2, 130.9, 128.5 (
1
JC-P = 55.0 Hz, 2C), 128.3 (JC-P = 11.0 Hz), 128.1 (JC-P = 11.0 
Hz), 125.9, 125.1; 
31
P-NMR (trans and cis isomers): 7.24 (
1
JP-Pt = 3904 Hz, cis isomer); 2.59 (
1
JP-Pt 
= 3581 Hz, trans isomer); 
195
Pt-NMR (trans and cis isomers): -3379 (
1
JPt-P = 3904 Hz, cis isomer); -
3540 (
1
JPt-P = 3581 Hz, trans isomer); A sample of solid was dissolved in CHCl3 and crystallized by 
slow diffusion of pentane vapors. Some single crystals were selected for X-ray diffraction analysis, 
which revealed the trans stereochemistry of the complex. 
31
P-NMR (crystals in CDCl3, freshly 
prepared solution): 2.59 (
1
JP-Pt = 3581 Hz). 
2.3.2. Synthesis of trans- + cis-[PtCl2(PPh3)(pyrz)] (7a + 7b) 
Method a. A suspension of 0.139 g (0.244 mmol) of cis-[PtCl2(PPh3)(NCMe)] in 15.0 mL of 1,2-
DCE was treated with a large excess of pyrazine (pyrz/Pt molar ratio = 10) and refluxed (3h). A 
yellow solution was initially obtained and, upon cooling, a colorless powder formed, which was 
filtered, washed with heptane, dried and characterized (7b, isomer cis, 0.0129 g, 14 % yield). The 
filtrate was treated under vacuum (10
-2
 mmHg) up to dryness. The solid residue was washed with 
several portions of diethyl ether to remove the pyrazine excess. The light yellow powder was dried 
under vacuum (trans + cis isomers, 7a + 7b; 0.0178 g, 21 % yield). Anal. Calcd. for 
C22H19Cl2N2PPt: C 43.4, H 3.2, N 4.6 %. Found: C 43.6, H 3.0, N 4.6 %. IR (ATR, cm
-1
): 3053; 
1482; 1417; 1098; 996; 804; 746; 692;
 1
H-NMR (isomer cis): 8.40 (dd, 2H, 
3
JH-H = 4.4 Hz, 
5
JH-H = 
1.3 Hz, 
3
JH-Pt = 41 Hz, PtNCH), 8.18 (dd, 2H, 
3
JH-H = 4.4 Hz, 
5
JH-H = 1.3 Hz, PtNCHCH), 7.69 (m, 
6H, Harom phosphine), 7.48 (m, 3H, Harom phosphine), 7.37 (m, 6H, Harom phosphine); 
1
H-NMR 
(isomer trans, selected signals from 
1
H-NMR of the mixture): 9.09 (m, 2H, 
3
JH-Pt = 21 Hz, PtNCH), 
8.79 (m, 2H, PtNCHCH), 7.81 (m, 6H, Harom phosphine), 7.50 (m, 9H, Harom phosphine). 
31
P-NMR 
(isomer cis): 7.13 (
1
JP-Pt = 3808 Hz); 
31
P-NMR (isomer trans, selected signal from 
31
P-NMR of the 
mixture): 2.68 (
1
JP-Pt = 3661 Hz). 
A solution of 7b in CDCl3 was monitored through 1H-NMR spectroscopy. Formation of 7a, 1 and 
free pyrazine was observed. The equilibrium composition was reached after about 48 h. The relative 
concentrations of the species involved in the equilibrium were obtained by the integrals of the 
signals at 9.09 and 8.79 ppm for 7a, 8.40 and 8.18 ppm for 7b, 9.33 ppm for 1, 8.62 ppm for free 
pyrz. 
Method b. A suspension of 0.201 g (0.177 mmol) of 1 in 1,2-DCE (9.0 mL) was treated with 0.0400 
g of pyrazine (0.500 mmol, pyrz/ Pt molar ratio = 1.42) under stirring at room temperature and 
turned quickly to a yellow-green solution. A sample of the solution was analyzed after 30 minutes 
(
31
P-NMR) and showed two signals: 2.78 ppm (65 %, 
1
JP-Pt = 3685 Hz), 6.36 ppm (35 %, 
1
JP-Pt = 
3790 Hz). After 30 minutes the mixture was concentrated under vacuum until a pale yellow solid 
formed. After two days the solid was filtered, washed with heptane (2 × 2.0 mL) and dried under 
vacuum (63% yield). 
1
H- and 
31
P-NMR, carried out in CDCl3 solution showed the presence of 
isomer cis (66 %) and isomer trans (34 %, cfr. characterization described for method a). 
2.3.3. Treatment of 2 with bipy with formation of trans- + cis-[PtCl2(PPh3)(bipy)] (8a + 8b) 
To a solution of (trans,trans)-[{PtCl2(PPh3)}2(µ-bipy)], 2, in CD2Cl2 bipy was added in two 
portions corresponding to bipy/2 molar ratios 1 and 2, respectively. After each addition the system 
was monitored by 
1
H-and 
31
P-NMR spectroscopies (Table 3SI).  
2.3.4. Isomerization of 2 to (cis,cis)-[{PtCl2(PPh3)}2(µ-bipy)], 2b. 
A sample of (trans,trans)-[{PtCl2(PPh3)}2(µ-bipy)] was dissolved in chloroform in the presence of 
a slight amount of bipyridyl. After two weeks, colorless crystals separated out of the solution. 
1
H-
NMR (CDCl3): 8.55 (m, 4H, NCH); 7.72 (m, 12H, Harom phosphine); 7.49 (m, 6H, Harom 
phosphine); 7.38 (m, 12H, Harom phosphine); 7.00 (m, 4H, NCHCH). A single crystal was selected 
for X-ray diffraction analysis, which confirmed the (cis,cis) stereochemistry. 
2.3.5. Treatment of 3 with pipz with formation of trans-[PtCl2(PPh3)(pipz)], 9. 
To a solution of (trans,trans)-[{PtCl2(PPh3)}2(µ-pipz)], 3, in CD2Cl2 piperazine was added in two 
portions corresponding to pipz/3 molar ratios 0.5 and 2, respectively. After each addition the system 
was monitored by 
1
H- and 
31
P-NMR (Table 4SI). 
2.4. X-ray structure determinations 
The X-ray diffraction experiments were carried out at room temperature by means of a Bruker 
Smart Breeze CCD diffractometer operating with graphite-monochromated Mo-K radiation. The 
samples were sealed in glass capillaries and their lattice parameters were evaluated as a preliminary 
step to the crystallographic study (Table 1). On the basis of these results the intensity data 
collections were done up to the limits mentioned in the table. The low limit adopted in the 
collection of intensities of 2·is mainly due to the disorder which sharply cuts down the diffraction 
intensities at high  values. The intensities were corrected for Lorentz and polarization effects and 
for absorption by means of a multi-scan method.[10] The structure solutions were obtained by the 
automatic direct methods contained in SHELX97 program.[11] After the completion of the main 
molecule model, the difference Fourier maps of 2, 3 and 6a showed clusters of broad maxima 
placed within cavities still present in the crystal structure. These were regarded as the crystallization 
solvent molecules affected by different degrees of disorder. In the crystal structure of 3 a cluster of 
maxima was attributed to a disordered chloroform molecule, while in the structure of 6a the cluster 
was recognized as a 1,2-dichloroethane placed on an inversion centre. The residual maxima in the 
difference Fourier maps of the structures of 2 and 3, are probably due to a heavily disordered 
solvent molecule, most likely n-heptane, but cannot be fitted with any reasonable conformer of this 
species. So the intensity data for those two structures were treated with the SQUEEZE[12] 
procedure in order to remove the contribution of the disordered solvent still missing from the 
model.  
After the introduction of hydrogen atoms in calculated positions all the heavy atoms of the main 
molecules were refined with anisotropic displacement parameters up to the reliability factors listed 
in Table 1. The presence of disorder limits the accuracy of some of these refinements but still lets 
discuss with a sufficient degree of reliability the connectivity and conformation of the main 
molecules. 
In addition to the aforementioned software, other control calculations and preparation of publication 
material were performed with the programs contained in the suite WINGX.[13] 
Table 1. Crystal data and structure refinements for compounds 2-3a 
Compound 2  2b 3 · 2(CHCl3) 
Empirical formula  C46H38Cl4N2P2Pt2 C46H38Cl4N2P2Pt2 C42H42Cl10N2P2Pt2 
Formula weight  1212.70 1212.70 1381.39 
Crystal system  Monoclinic Orthorhombic Monoclinic 
Space group  P21/c (No. 14) Pb ca  (No. 61) C2 /c  (No. 15) 
a / Å 10.0774(19) 10.8826(4) 25.1921(5) 
b / Å 9.5758(18) 15.5332(5) 16.3487(3) 
c / Å 28.126(5) 24.8585(9) 14.0157(3) 
  / ° - - - 
  / ° 99.639(8) - 103.0420(10) 
  / ° - - - 
U / Å3 2675.8(9) 4202.1(3) 5623.6(2) 
Z 2 4 4 
Dcalc / Mg·m3 1.505 1.917 1.632 
  / mm1 5.510 7.018 5.539 
max  /° 23.81 25.79 30.45 
No. measured 17030 13715 28828 
No. unique [Rint] 4081 [0.0404] 3928 [0.0597] 8269 [0.0354] 
No. parameters 255 253 281 
R1, wR2 [I >2 (I )] 
a 0.0294, 0.0650 0.0408, 0.0808 0.0478, 0.1362 
R1, wR2 [all data] 
a 0.0440, 0.0688 0.0870, 0.0941 0.0863, 0.1593 
Goodness of fit b on F 2 0.879 0.976 0.794 
a Crystal data and structure refinements for complex 6a are reported in Table 5SI. b R(Fo) = FoFc  Fo; 
Rw(Fo
2) = [[w(Fo
2Fc
2)2 ] / [ w(Fo
2)2]]½ ; w = 1 / [ 2 (Fo
2) + (AQ)2 + BQ] where Q = [MAX(Fo
2,0) + 2Fc
2] / 3; GOF = 
[ [w(Fo
2–Fc
2)2]/(N–P)]½, where N, P are the numbers of observations and parameters, respectively 
 
3. Results and discussion 
3.1. Syntheses. 
The syntheses of the dinuclear complexes 1-4, [{PtCl2(PPh3)}2(µ-N―N)], were carried out by 
reacting cis-[PtCl2(PPh3)(NCMe)][7e]
 with the nitrogen bidentate divergent N―N ligands in molar 
ratio 2:1 (Scheme 1). 
2
1,2-DCE
reflux
=
1-4
4,4'-bipyridyl (bipy, trans,trans-2)
(X-ray diffraction)
p-xylylendiamine (pxylN2, 4)piperazine (pipz, trans,trans- 3)
(X-ray diffraction)
pyrazine (pyrz, 1)
 
Scheme 1. Synthesis of the dinuclear complexes 1-4 
The reactions were carried out in refluxing 1,2-DCE for two reasons: a) under these conditions fast 
isomerisation of the precursor to the trans form is observed; b) at lower temperature attack to the 
nitrile is possible in the case of the secondary and primary amine.[7b,d] The processes were 
monitored by 
31
P-NMR spectroscopy and in all cases the signal attributable to the platinum 
precursor (4.83 ppm, 
1
JP-Pt = 3570 Hz) disappeared in about 3 hours, while a new signal with 
satellites was observed (Table 2). 
Table 2. Observed 31P-NMR signals in dinuclear complexes 1-4. 
product N―N δ/ppm (1JP-Pt/Hz) 
1 pyrz 2.79 (3728) 
2 bipy 2.64 (3611) 
3 pipz 3.56 (3603) 
4 pxylN2 3.87 (3646) 
 
A yellow, crystalline solid product separated out of each reaction mixture or precipitated upon 
addition of heptane. Spectroscopic analyses were carried out on the isolated complexes. The 
31
P-, 
13
C- and 
195
Pt-NMR (CDCl3) spectra were in agreement with the presence of a single product. In the 
1
H-NMR spectra the N―N hydrogen atoms closest to the coordination centers showed downfield 
shifted signals with respect to the free ligand (Table 1 SI). Moreover, in each case, the integration of 
the observed 
1
H-NMR signals matched with a 1:2 molar ratio between the coordinated N―N and 
PPh3, in accordance with the dinuclear nature of the complexes. Elemental analyses too were in 
good agreement with the proposed formulas. 
Similar dinuclear complexes containing pyrazine-derived ligands had been described in a previous 
study [6a] concerning the reactivity of chloro-bridged dinuclear derivatives [Pt2(μ-Cl)2Cl2L2], 
(L=PEt3, PMe2Ph, PMePh2, ethylene). In the article, the authors underline the importance of the 
molar ratio between the reagents in directing the synthesis to dinuclear or mononuclear derivatives. 
The dinuclear products showed trans,trans geometry, while the formation of other geometric 
isomers was not observed. As for our cases, the prompt isomerisation of the precursor, cis-
[PtCl2(NCMe)(PPh3)],[7d,e] to the trans-complex (T = 80 °C) is consistent with the formation of 
the trans,trans dinuclear isomer as kinetic product, in view of the well-known trans effect exerted 
by triphenylphosphine. Nevertheless, geometrical isomerization of the product in solution (Figure 
1) could not be excluded a priori. As a matter of fact, the presence of a single signal with satellites 
in 
31
P-NMR spectra of complexes 1-4 allowed to rule out the trans,cis geometry, but both 
trans,trans and cis,cis isomers were compatible with the observed pattern. 
trans,trans
trans,cis
cis,cis
 
Figure 1: Possible geometric isomers for [{PtCl2(PPh3)}2(µ-N―N)] complexes 
Single crystal X-ray diffraction studies established the square planar coordination around platinum 
centers and the trans,trans geometry for complexes 2 and 3 (See 3.2). 
Since the observed 
31
P-NMR chemical shifts and 
1
JP-Pt coupling constants (Table 2) are similar for 
all dinuclear compounds 1-4, we can assign them a common trans,trans geometry. The pure 
complexes do not isomerize in CHCl3 solution, as checked by 
31
P-NMR. 
The synthetic procedure can be extended to higher nuclearity complexes following the denticity of 
the divergent ligand. As an example, the tridentate ligand py3TRIA [8] was reacted with trans-
[Pt(µ-Cl)2Cl2(PPh3)2] in 1,2-DCE affording a product identified as (trans,trans,trans)-
[{PtCl2(PPh3)}3(µ-py3TRIA)], 5 (see experimental details and discussion in SI). 
Within this study the reaction of cis-[PtCl2(PPh3)(NCMe)] [7e] with N―N in 1/1 molar ratio 
(Scheme 2) was tested. It is expected the formation of mononuclear complexes, retaining one 
dangling donor atom on the bidentate divergent ligand (Scheme2). 
 
Scheme 2. Synthesis of mononuclear complexes 
However, the literature reports that mononuclear species of the type trans-[PtCl2L(N―N)] (L = 
phosphine or CH2=CH2 and N―N a bidentate divergent hetero-aromatic base) are in equilibrium 
with the corresponding trans,trans dimers [{PtCl2(PPh3)}2(µ-N―N)] (Scheme 3).[6a] 
2
 
Scheme 3. Equilibrium between mononuclear and dinuclear species. 
When the reaction between cis-[PtCl2(PPh3)(NCMe)] and pyrazine was carried out with molar ratio 
1:1, preliminary results showed the presence of a complex system containing the dinuclear 
trans,trans derivative 1, free pyrazine and two mononuclear products, as revealed by the 
1
H-NMR 
spectrum of the reaction mixture. The most reasonable hypothesis was that both geometrical 
isomers of the mononuclear product were formed. Nevertheless, in previous experiences concerning 
the preparation of [PtCl2(PPh3)(NHRR')] with a series of monodentate aliphatic amines [7a-d,14], 
the exclusive formation of trans-[PtCl2(PPh3)(NHRR')] complexes was observed and no 
isomerisation of the product was detected, probably because of the higher stability of these 
geometric isomers.[7a-d,14] It could be expected that also the reaction sketched in Scheme 2 
afforded the trans isomer of the mononuclear product. Anyway, since heteroaromatic bases in place 
of amines could in principle affect the relative stability of the two geometrical isomers,[15] we first 
studied the reaction between cis-[PtCl2(PPh3)(NCMe)][7e] and pyridine, as the monodentate base 
allowed to reduce the number of species present at equilibrium. The reaction, monitored by 
31
P-
NMR spectroscopy, proceeded to completion in a couple of hours with formation of two products. 
Two signals of about the same intensity [2.59 ppm (
1
JP-Pt = 3583 Hz) and 7.24 ppm (
1
JP-Pt = 3902 
Hz)] were observed. Moreover, the solid product obtained after the work up of the reaction mixture 
showed an elemental analysis in agreement with the formula [PtCl2(PPh3)(py)]. Solutions of the 
product revealed in the 
31
P-NMR spectrum the two signals previously observed in the spectrum of 
the reaction mixture. These data showed that we were dealing with the two geometrical isomers cis- 
and trans-[PtCl2(PPh3)(py)] (Scheme 4). 
x (1-x) Py
2.59 ppm (1J
P-Pt
 = 3583 Hz)
(X-ray diffraction)
6a 6b
7.24 ppm (1JP-Pt = 3902 Hz)
 
Scheme 4. Synthesis of [PtCl2(py)(PPh3)] 
 
A sample was dissolved in CHCl3 and pentane was added by slow diffusion with formation of 
single crystals suitable for X-ray diffraction studies which showed that the isomer trans-
[PtCl2(PPh3)(py)] had been separated by crystallization (Figure 1.SI). 
The NMR spectra of a freshly prepared solution of the crystals allowed the assignment of the 
resonances due to the trans isomer and as a consequence also to the cis isomer. At variance with the 
previously reported cases involving the aforementioned amines,[7a-d] both the geometric isomers 
formed with pyridine (Scheme 4). 
This outcome supported our hypothesis concerning the formation of both geometrical isomers of the 
mononuclear product [PtCl2(PPh3)(pyrz)] by reacting cis-[PtCl2(PPh3)(NCMe)] with pyrazine in 
molar ratio 1:1. The reaction, carried out with an excess of pyrazine, yielded a suspension of a 
colourless solid that was recovered by filtration and characterized by NMR spectroscopy. Its 
31
P-
NMR (CDCl3) spectrum showed a single signal at 7.13 ppm (
1
JP-Pt = 3810 Hz), while the integration 
of 
1
H-NMR signals confirmed the mononuclear nature of the product, that was supported also by 
elemental analysis data. On the basis of 
31
P-NMR analogy with 6b, the complex was identified as 
cis-[PtCl2(PPh3)(pyrz)] (7b). From the filtrate of the reaction mixture a second crop of solid was 
obtained, containing 7b and a second product showing the same composition, corresponding to the 
geometric isomer trans-[PtCl2(PPh3)(pyrz)] (7a) according to its NMR spectral features. Selected 
1
H- and 
31
P-NMR signals of 7a, 7b are reported in Table 3, together with those of 1, 6a, 6b and free 
pyrazine. 
Table 3. Selected 1H- (Pt-NCH) and 31P-NMR signals of 
free pyrz, 1, 6 and 7 in CDCl3
 
Species 1H/ppm (3JH-Pt/Hz) 
31P/ppm (1JP-Pt/Hz) 
pyrazine 8.59 / 
1 9.33 (nd) 2.79 (3728) 
6a 9.03 (32) 2.59 (3583) 
6b 8.45 (40) 7.24 (3902) 
7a 9,09 (21) 2.69 (3662) 
7b 8,40 (41) 7.13 (3810) 
nd= not detectable 
For both isomers it was possible to measure 
3
JH-Pt for hydrogen atoms closest to coordinated 
nitrogen, with cis isomer showing a higher coupling constant. It has to be underlined that trans 
mononuclear 7a and dinuclear 1 complexes show very similar 
31
P-NMR chemical shifts and 
1
JP-Pt 
coupling constants, so that it is necessary to carry out an accurate integration of 
1
H-NMR signal to 
clearly distinguish between the two species. A mixture of the two isomers 7a and 7b was also 
obtained by reacting trans-[Pt2(µ-Cl)2Cl2(PPh3)2] with a slight excess of pyrazine (pyrz/Pt molar 
ratio = 1.3). 
In a further experiment, the formation of the mononuclear derivatives was studied starting from the 
dinuclear complex 1 that was dissolved in CDCl3 into an NMR test tube and treated with portions of 
pyrazine (Table 2 SI). After the first addition corresponding to a pyrz/1 molar ratio = 1), both 1 and 
7a were observed (
1
H- and 
31
P-NMR). After the further addition (pyrz/1 molar ratio = 2), signals 
due to 1 disappeared and the mononuclear trans-complex 7a was initially detected as the main 
component. However, partial isomerisation to the cis-complex 7b was soon observed in solution 
(Scheme 5). Although both isomers were present in solution, the lower solubility of 7b allowed its 
separation in pure form. 
7a 7b
1
Scheme 5. Equilibria for the system 1/pyrz.  
A sample of pure 7b was dissolved in CDCl3 and 
1
H- and 
31
P-NMR spectra were recorded. They 
clearly show both partial isomerization to 7a and partial dimerization to 1. The equilibrium 
composition at room temperature was reached in about 48 h. The 
1
H-NMR spectrum integrals 
allowed the assessment of the equilibrium constant concerning the reaction sketched in Scheme 3 
(N-N = pyrz). The constant, calculated as K = {[1] × [pyrz]}/{[7a] + [7b]}2, corresponded to about 
5.4 × 10
-3
. This value is similar to that reported in the literature for an analogous system where only 
the trans isomer of the mononuclear species was detected.[6a]  
The reaction of the trans,trans dinuclear 2 complex with bipy to obtain the mononuclear derivative 
[PtCl2(PPh3)(bipy)], was similarly monitored by 
1
H- and 
31
P-NMR in CD2Cl2 as solvent. Selected 
spectroscopic data are reported in Table 3SI, together with the characteristic resonances for 
dinuclear 2 in the same solvent. Since 
1
H-NMR signals of different species were partially 
superposed, it was not possible to integrate them correctly, nevertheless the main features of the 
system could be described. 
For a bipy/2 molar ratio of 1, 
31
P-NMR spectrum did not vary appreciably, while two new signals 
with the same intensity appeared in the 
1
H-NMR spectrum (9.14 and 8.79 ppm), besides a multiplet 
due to free bipy (8.75 ppm) and the signal of dinuclear 2 (9.20 ppm). Signals at 9.14 and 8.79 ppm 
were ascribed, in analogy with the system 1/pyrz, to trans-[PtCl2(PPh3)(bipy)] (8a). It has to be 
noted that 
31
P-NMR signals of 2 and 8a were not distinguishable in CD2Cl2. For a bipy/2 molar 
ratio of 2, the signals due to 2 disappeared in 
1
H-NMR spectrum, where, besides the multiplets due 
to free bipy and 8a, a new one at 8.59 ppm was attributed to the mononuclear species cis-
[PtCl2(PPh3)(bipy)] (8b). The molar ratio between 8a and 8b was estimated about 1. In a few days a 
colorless solid separated out and single crystals were chosen for structural X-ray determination 
(Figure 5). Quite unexpectedly, the solid turned out to be the dinuclear complex with cis,cis 
geometry (cis,cis)-[{PtCl2(PPh3)}2(µ-bipy)], 2b).  
Despite the very scarce solubility of the complex 2b in CD2Cl2 it was possible to carry out a 
1
H-
NMR experiment, showing the following, not previously observed signals (Figure 2):  8.55 (m, 
4H, Hα); 7.72 (m, 12H, PPh3); 7.49 (m, 6H, PPh3); 7.38 (m, 12H, PPh3); 7.00 (m, 4H, Hβ). 


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Figure 2. Magnetically non-equivalent bipy hydrogen nuclei in 2b. 
All these data can be rationalized by the simultaneous presence of equilibria concerning the 
nuclearity of the species, their geometrical isomerism and, finally, their solubility (Scheme 6). It is 
to be underlined that trans to cis isomerization of both mononuclear and dinuclear species appears 
detectable only in the presence of free ligand. This behavior is in agreement with the known 
catalytic effect of free ligands in the isomerization processes concerning platinum(II) complexes. 
(trans,trans)-[PtCl
2
(PPh
3
)
2
(µ-bipy)] + bipy trans-[PtCl
2
(bipy)(PPh
3
)]
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8b
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2
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3
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2
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3
)
2
(µ-bipy)] + bipy
2b
X-ray diffraction  
Scheme 6. Equilibria involving the system “2/bipy”  
For the system “3 + piperazine”, where a secondary aliphatic diamine was involved, the formation 
of a single product was revealed by 
31
P- and 
1
H-NMR spectroscopy in the presence of an excess of 
the ligand, reasonably the mononuclear complex trans-[PtCl2(PPh3)(pipz)] (9), by comparison with 
the NMR parameters of the products discussed before (Table 4 SI). 







 
 
Figure 3. Magnetically non-equivalent piperazine hydrogen nuclei in 9. 
1
H-NMR spectrum of mononuclear complex 9 is characterized by five signals for non-equivalent 
hydrogen atoms (Figure 3), while a signal with satellites is present in the 
31
P-NMR spectrum, with 
values of chemical shift and coupling constants very close to those observed for the trans dinuclear 
precursor. Moreover, at variance with systems containing heteroaromatic ligands (py, pyrz and 
bipy), no isomerization of the piperazine complexes was observed. 
When the preparation of 9 was attempted by using a stoichiometric amount of piperazine, an 
equilibrium involving 3, 9 and the free ligand was again observed (Scheme 3). The integration of 
1
H-NMR signals allowed an assessment of the constant of the equilibrium K = {[3] × [piper]}/[9]2, 
corresponding to about 0.15. 
3.2 Structural determinations 
Selected bond lengths and angles for complexes 2, 2b and 3 (Figures 4-6) are summarized in Table 
4. The Pt coordination is square planar with very little distorsions presumably due to the 
encumbrance of the different ligands. The Cambridge Crystallographic Database [Errore. Il 
segnalibro non è definito.] contains the structural data of several compounds including the unit 
{PtCl2aminophosphine}, more commonly with the chloride ligands in trans configuration (43 
examples) and less commonly in the cis one (8 examples). The bond lengths we found in our 
compounds (Table 4) are all within the range of expected values: 2.30(2) Å for PtCl trans to Cl, 
2.36(1) Å for PtCl trans to the phosphine, 2.03(2) Å for PtN trans to Cl, 2.13(4)Å for PtN trans 
to the phosphine and 2.23(1) Å for PtP. 
Table 4. Bond lenghts [Å] and angles [°] around Pt atom 
 2 2b 3 
Pt–N  2.102(5) 2.035(6) 2.138(5) 
Pt–P  2.2272(14) 2.249(2) 2.2388(15) 
Pt–Cl(1) 2.2731(16) 2.299(2) 2.289(2) 
Pt–Cl(2)  2.2791(16) 2.348(2) 2.2872(18) 
N–Pt–P 178.47(13) 93.25(18) 179.79(15) 
N–Pt–Cl(1) 87.85(13) 175.22(18) 89.07(17) 
N–Pt–Cl(2) 88.82(13) 86.55(18) 83.61(17) 
P–Pt–Cl(1) 93.67(6) 91.44(8) 90.78(7) 
P–Pt–Cl(2) 89.66(6) 178.58(8) 96.55(7) 
Cl(1)–Pt–Cl(2) 176.67(6) 88.74(8) 172.19(7) 
 
 
The molecular structures of 2 and 2b are reported in figures 4 and 5. 
The metal coordination planes in 2 are parallel and almost coplanar (deviation 0.23 Å). The plane of 
the bipyridyl ligand makes with them a dihedral angle of 53.4°. 
 
Figure 4  View of the molecular structure of 2 as found in the crystals of 2 . Thermal ellipsoids are at 20% probability. ' 
= 3  x,  y, 2  z. 
  
 
 
Figure 5. View of the molecular structure of 2b. Thermal ellipsoids are at 20% probability. ' = 2  x,  y, 1  z. 
 
In 2b (Figure 5) platinum coordination planes are parallel and almost coplanar (deviation 0.20 Å) 
and make a dihedral angle of 70.7° with the plane of the bipyridyl ligand. It is worth to note that 
each phosphine ligand have a phenyl group slanted towards the nearest pyridyl ring. The two rings 
are almost parallel (dihedral angle 13.9°) with a relatively short distance between the centroids 
(3.56 Å), suggesting an intramolecular -stacking interaction. 
The platinum coordination planes in 3 (Figure 6) are again parallel and almost coplanar. The 
hydrogen atom connected with the nitrogen N(1) also lies on the metal coordination plane with a 
N(1)Pt(1)Cl(2) angle of 83.3°, suggesting at some extent a H···Cl(2) interaction. 
 
Figure 6. View of the molecular structure of 3 as found in the crystals of 3 · 2 (CHCl3) . Thermal ellipsoids are at 20% 
probability. ' = 1  x, 1  y, 2  z. 
4. Conclusions 
The preparation of dinuclear complexes [{PtCl2(PPh3)}2(µ-N―N)], where N―N = nitrogen 
bidentate divergent ligand, can be carried out with good yields starting from cis-
[PtCl2(PPh3)(NCMe)], with an accurate control of the molar ratio between reagents (Pt/N―N molar 
ratio = 2). Products, characterized by trans,trans geometry, appear stable in solution for many days. 
If a different molar ratio between reagents is used (Pt/N―N molar ratio = 1) equilibria are 
established involving the already described dinuclear derivatives, the corresponding mononuclear 
complexes [PtCl2(PPh3)(N―N)] and the free ligand. Equilibrium constants were estimated as 
instability constants of the mononuclear species containing pyrazine (K = 5.4·10-3) and piperazine 
(K = 0.15). The comparison between the obtained values show the higher stability of the 
mononuclear species containing the heteroaromatic base. The existence of such equilibria suggests 
some prudence in planning syntheses involving the mononuclear complexes of the type here 
described. For instance, they could in principle be considered suitable precursors of heterobimetallic 
dinuclear compounds, as they retain one dangling donor atom on the bidentate divergent ligand, 
able to penetrate the coordination sphere of another metal, Nevertheless, in view of their facile 
dimerization, a mixture of products could be obtained. Under the conditions useful to obtain 
mononuclear derivatives, the geometrical isomerization of the species in solution was observed with 
the heteroaromatic bases pyrazine and 4,4'-bipyridyl. Moreover, besides isomerization and 
dimerization equilibria, solubility can play a role. For instance, in the case of the bipy based system, 
the very low solubility of the dinuclear (cis,cis)-[{PtCl2(PPh3)}2(µ-bipy)], 2b, allowed its isolation 
and structural characterization. 
With the secondary diamine piperazine, only products (both dinuclear and mononuclear) with trans 
geometry were observed, even when an excess of the ligand was added. This result is in agreement 
with previous data,[7a-d,14] where platinum(II) complexes containing amines of the type (trans)-
[PtCl2(PPh3)(RR’NH)] did not show any isomerization to the cis isomers in solution, probably for 
the significantly higher stability of the isomer having the π-acid phosphine trans to the rather basic 
amine. 
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Appendix A. Supplementary data 
Experimental details concerning the preparation of 5 as well as some spectroscopic data are 
reported as Supplementary Information. 
CCDC 1484284-1484287 contain the supplementary crystallographic data for the derivatives 2·, 2b, 
3·2(CHCl3) and 6a·0.5(C2H4Cl2). These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif 
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